Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 1 , Pages 36-37 , March 2008

Photofrin PDT for Barrett's oesophagus with high-grade dysplasia

  • J.A.C. Thorpe, FRCS

      Affiliations

    • St James University Hospital, Leeds, UK
    • Yorkshire Laser Centre, Goole & District Hospital, Woodland Avenue, Goole, East Yorkshire, UK
  • K. Moghissi, MD, FRCS

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 1724 290456.

References 

  1. McCaughan JS, Nims TA, Guy JT, Hicks WJ, Williams TE, Laufman LR. Photodynamic Therapy for oesophageal tumours. Arch Surg. 1989;124:74–80
  2. Hyata Y, Kato H, Okitsu H, Kawaguchi M, Konaka C. Photodynamic Therapy with haematoporphyrin derivative in cancer of the upper gastro-intestinal tract. Semin Surg Oncol. 1985;1:1–11
  3. Moghissi K, Dixon K, Thorpe JAC, Stringer M, Moore PJ. The role of Photodynamic Therapy (PDT) in inoperable oesophageal cancer. Eur J Cardiothorac Surg. 2000;17:95–100
  4. Tian ME, Qui SL, Ji Q. Preliminary results of haematoporphyrin derivative-laser treatment for 13 cases of early oesophageal carcinoma. Adv Exp Med Biol. 1985;193:21–25
  5. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after Photodynamic Therapy for oesophageal cancer. Gastroentol. 1995;109:1406–1407
  6. Barrett NR. The lower oesophagus lined by columnar epithelium. Surgery. 1957;41:881–894
  7. Schwesinger WH. Endoscopic diagnosis and treatment of mucosal lesions of the oesophagus. Surg Clin N Am. 1989;69:1185–1203
  8. Overholt BF, Panjehpour M. Photodynamic Therapy in Barrett's oesophagus: reduction of specialised mucosa, ablation of dysplasia and treatment of superficial oesophageal cancer. Semin Surg Oncol. 1995;11:372–376
  9. Overholt BF, Panjehpour M. Photodynamic Therapy for Barrett's oesophagus. Gastrointest Endosc Clin N Am. 1997;7:207–220
  10. Overholt BF, Lightdale CJ, Wang KK, et al. International Photodynamic Group for High-Grade Dysplasia in Barrett's oesophagus. Photodynamic Therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's oesophagus: international, partially blinded, randomised phase III trial. Gastrointest Endosc. 2005;62:488–498
  11. Overholt BF, Wang KK, Burdick JS, et al. International Photodynamic group for High-Grade Dysplasia in Barrett's oesophagus. Five-year efficiency and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc. 2007;66:460–468
  12. Moghissi K, Sharpe DAC, Pender D. Adenocarcinoma and Barrett's oesophagus: a clinico-pathological study. Eur J Cardiothorac Surg. 1993;7:126–132
  13. Sujendran V, Sica G, Warren B, Maynard N. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. Eur J Cardiothorac Surg. 2005;28:763–766
  14. Barr H. Controversial topics in surgery. High-grade dysplasia in Barrett's oesophagus. The case against oesophageal resection. Ann R College Surg Eng. 2006;99:586–590
  15. Maynard ND. Controversial topic in surgery. The case for oesophageal resection. Ann R Coll Surg Eng. 2006;89:586–590

PII: S1572-1000(08)00008-2

doi: 10.1016/j.pdpdt.2008.01.007

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 1 , Pages 36-37 , March 2008

Article Tools